Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  vandetanib
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 11-0265, NCI-2011-01246, NCT01414426
Vandetanib in Treating Patients with Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and older
Trial IDs: 201301763, NCI-2013-01699, 02130107, NCT01934335
Vandetanib in Treating Patients with Wild-Type Gastrointestinal Stromal Tumors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 3 and over
Trial IDs: 13-C-0208, NCI-2014-02460, 130208, P131258, NCT02015065
Vandetanib and Everolimus in Treating Patients with Advanced or Metastatic Cancer
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: 2011-0953, NCI-2012-00782, NCT01582191
Start Over